Literature DB >> 25817710

Amygdala signals subjective appetitiveness and aversiveness of mixed gambles.

Sofie V Gelskov1, Susanne Henningsson2, Kristoffer H Madsen3, Hartwig R Siebner4, Thomas Z Ramsøy5.   

Abstract

People are more sensitive to losses than to equivalent gains when making financial decisions. We used functional magnetic resonance imaging (fMRI) to illuminate how the amygdala contributes to loss aversion. The blood oxygen level dependent (BOLD) response of the amygdala was mapped while healthy individuals were responding to 50/50 gambles with varying potential gain and loss amounts. Overall, subjects demanded twice as high potential gain as loss to accept a gamble. The individual level of loss aversion was expressed by the decision boundary, i.e., the gain-loss ratio at which subjects accepted and rejected gambles with equal probability. Amygdala activity increased the more the gain-loss ratio deviated from the individual decision boundary showing that the amygdala codes action value. This response pattern was more strongly expressed in loss aversive individuals, linking amygdala activity with individual differences in loss aversion. Together, the results show that the amygdala signals subjective appetitiveness or aversiveness of gain-loss ratios at the time of choice.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amygdala; Decision-making; Loss aversion; Ventral striatum; fMRI

Mesh:

Year:  2015        PMID: 25817710     DOI: 10.1016/j.cortex.2015.02.016

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  2 in total

1.  Combined Effects of Glucocorticoid and Noradrenergic Activity on Loss Aversion.

Authors:  Zsofia Margittai; Gideon Nave; Marijn Van Wingerden; Alfons Schnitzler; Lars Schwabe; Tobias Kalenscher
Journal:  Neuropsychopharmacology       Date:  2017-04-14       Impact factor: 7.853

2.  Fear-induced increases in loss aversion are linked to increased neural negative-value coding.

Authors:  Stefan Schulreich; Holger Gerhardt; Dar Meshi; Hauke R Heekeren
Journal:  Soc Cogn Affect Neurosci       Date:  2020-07-30       Impact factor: 3.436

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.